Quantitative Sensory Testing (QST) - Does assessing ... - TI Pharma
Quantitative Sensory Testing (QST) - Does assessing ... - TI Pharma Quantitative Sensory Testing (QST) - Does assessing ... - TI Pharma
Visentini PJ, Khan KM, Cook JL, Kiss ZS, Harcourt PR, Wark JD. 1998. The VISA score: an index of severity of symptoms in patients with jumper’s knee (patellar tendinosis). Victorian Institute of Sport Tendon Study Group. J Sci Med Sport 1:22-8 Walk D, Sehgal N, Moeller-Bertram T, Edwards RR, Wasan A, et al. 2009. Quantitative sensory testing and mapping: a review of nonautomated quantitative methods for examination of the patient with neuropathic pain. Clin J Pain 25:632-40 Wang H, Sun H, Della Penna K, Benz RJ, Xu J, et al. 2002. Chronic neuropathic pain is accompanied by global changes in gene expression and shares pathobiology with neurodegenerative diseases. Neuroscience 114:529-46 Warden SJ, Kiss ZS, Malara FA, Ooi AB, Cook JL, Crossley KM. 2007. Comparative accuracy of magnetic resonance imaging and ultrasonography in confirming clinically diagnosed patellar tendinopathy. Am J Sports Med 35:427-36 Wasner G, Schattschneider J, Binder A, Baron R. 2004. Topical menthol--a human model for cold pain by activation and sensitization of C nociceptors. Brain 127:1159-71 Watkins LR, Maier SF. 2002. Beyond neurons: evidence that immune and glial cells contribute to pathological pain states. Physiol Rev 82:981-1011 Webborn AD. 2008. Novel approaches to tendinopathy. Disabil Rehabil 30:1572-7 Wicherts JM, Vorst HCM. 2004. Modeling the short Profile of Mood States and measurement variance in males and females (Dutch). Ned Tijdschr Psychol 5-25 Wiese-Bjornstal DM, Smith AM, Shaffer SM, Morrey MA. 1998. An integrated model of response to sport injury: Psychological and sociological dynamics. J Appl Sport Psychol 46-69 Winkelstein BA. 2004. Mechanisms of central sensitization, neuroimmunology & injury biomechanics in persistent pain: implications for musculoskeletal disorders. J Electromyogr Kinesiol 14:87-93 Wong MC, Chung JW, Wong TK. 2007. Effects of treatments for symptoms of painful diabetic neuropathy: systematic review. BMJ 335:87 Woolf CJ. 2010. Central sensitization: Implications for the diagnosis and treatment of pain. Pain Woolf CJ, Bennett GJ, Doherty M, Dubner R, Kidd B, et al. 1998. Towards a mechanism-based classification of pain? Pain 77:227-9 Woolf CJ, Mannion RJ. 1999. Neuropathic pain: aetiology, symptoms, mechanisms, and management. Lancet 353:1959-64 Woolf CJ, Salter MW. 2000. Neuronal plasticity: increasing the gain in pain. Science 288:1765-9 Yunus MB. 2009. Central Sensitivity Syndromes: An Overview. J Musculoskel Pain 400-8 Ziegler D. 2008. Treatment of diabetic neuropathy and neuropathic pain: how far have we come? Diabetes Care 31 Suppl 2:S255-61
Ziegler EA, Magerl W, Meyer RA, Treede RD. 1999. Secondary hyperalgesia to punctate mechanical stimuli. Central sensitization to A-fibre nociceptor input. Brain 122 ( Pt 12):2245-57 Zubieta JK, Heitzeg MM, Smith YR, Bueller JA, Xu K, et al. 2003. COMT val158met genotype affects mu-opioid neurotransmitter responses to a pain stressor. Science 299:1240-3 Zwerver J, Kramer T, van den Akker-Scheek I. 2009. Validity and reliability of the Dutch translation of the VISA-P questionnaire for patellar tendinopathy. BMC Musculoskelet Disord 10:102
- Page 63 and 64: 3. Somatosensory function and neuro
- Page 65 and 66: 3. Somatosensory function and neuro
- Page 67 and 68: 4. QST and neuropathic pain mechani
- Page 69 and 70: 4. QST and neuropathic pain mechani
- Page 71 and 72: 4. QST and neuropathic pain mechani
- Page 73 and 74: 4. QST and neuropathic pain mechani
- Page 75 and 76: 4. QST and neuropathic pain mechani
- Page 77 and 78: 4. QST and neuropathic pain mechani
- Page 79 and 80: 4. QST and neuropathic pain mechani
- Page 81 and 82: 5. QST in patients with tendinopath
- Page 83 and 84: 5. QST in patients with tendinopath
- Page 85 and 86: 5. QST in patients with tendinopath
- Page 87 and 88: 5. QST in patients with tendinopath
- Page 89 and 90: 5. QST in patients with tendinopath
- Page 91 and 92: 5. QST in patients with tendinopath
- Page 94 and 95: Chapter 6 General discussion and Su
- Page 96 and 97: 6. General discussion and Summary s
- Page 98 and 99: 6. General discussion and Summary s
- Page 100 and 101: 6. General discussion and Summary T
- Page 102 and 103: 6. General discussion and Summary Q
- Page 104 and 105: 6. General discussion and Summary S
- Page 106 and 107: References Abate M, Silbernagel KG,
- Page 108 and 109: de la Llave-Rincon AI, Fernandez-de
- Page 110 and 111: Kehlet H, Jensen TS, Woolf CJ. 2006
- Page 112 and 113: Robinson JM, Cook JL, Purdam C, Vis
- Page 116 and 117: Nederlandse samenvatting Met de ont
- Page 118 and 119: Acknowledgement To produce a work s
Ziegler EA, Magerl W, Meyer RA, Treede RD. 1999. Secondary hyperalgesia to<br />
punctate mechanical stimuli. Central sensitization to A-fibre nociceptor input.<br />
Brain 122 ( Pt 12):2245-57<br />
Zubieta JK, Heitzeg MM, Smith YR, Bueller JA, Xu K, et al. 2003. COMT<br />
val158met genotype affects mu-opioid neurotransmitter responses to a pain<br />
stressor. Science 299:1240-3<br />
Zwerver J, Kramer T, van den Akker-Scheek I. 2009. Validity and reliability of<br />
the Dutch translation of the VISA-P questionnaire for patellar tendinopathy.<br />
BMC Musculoskelet Disord 10:102
Change language